managing covid-19 risks and exposures in patients with myeloma
Published 1 year ago • 60 plays • Length 2:59Download video MP4
Download video MP3
Similar videos
-
2:55
covid-19 & multiple myeloma: patient management
-
10:14
managing myeloma in the covid-19 era
-
7:24
covid-19: outcomes in multiple myeloma
-
4:34
practical strategies to reduce exposure to covid-19
-
4:45
covid-19 risk factors in patients with hematologic malignancies
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
57:21
risks and responses: covid 19 vaccines and blood cancer patients
-
18:32
what all myeloma patients need to know in 2021: from myeloma 101 to vaccines and variants
-
1:07
how covid-19 has impacted clinical practice and treatment approaches in multiple myeloma
-
2:15
myeloma treatment and management in the covid era
-
3:13
the importance of improving the efficacy of covid-19 vaccination in patients with myeloma
-
3:09
an overview of the toxicities associated with immunotherapy in multiple myeloma
-
5:56
features of covid-19 infection in hematology patients
-
2:10
myeloma & covid-19: minimizing risk while maximising treatment
-
6:00
covid-19 and mpn updates
-
2:59
covid-19 & myeloma: maximising care and safety in the uk
-
2:20
ultra high-risk myeloma
-
3:57
updates from a study investigating exposure to pesticides and the risk of developing myeloma
-
1:29
insights into the biology of high-risk myeloma and advances being made in this space
-
3:43
the management of myeloma during the covid-19 pandemic
-
2:05
the impact of the covid-19 pandemic on myeloma treatment
-
4:15
impacts of covid-19 on patients with multiple myeloma